{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:07:30Z","timestamp":1788383250165,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"DOI":"10.1007\/s11845-026-04533-6","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T02:22:19Z","timestamp":1783131739000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Polypharmacy in glaucoma management: a narrative review"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6787-316X","authenticated-orcid":false,"given":"Annie","family":"Paisansirikul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8996-2868","authenticated-orcid":false,"given":"Sunee","family":"Chansangpetch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,4]]},"reference":[{"issue":"3","key":"4533_CR1","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.mcna.2021.01.004","volume":"105","author":"JM Kang","year":"2021","unstructured":"Kang JM, Tanna AP (2021) Glaucoma. Med Clin North Am 105(3):493\u2013510","journal-title":"Med Clin North Am"},{"issue":"10414","key":"4533_CR2","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/S0140-6736(23)01289-8","volume":"402","author":"H Jayaram","year":"2023","unstructured":"Jayaram H, Kolko M, Friedman DS et al (2023) Glaucoma: now and beyond. Lancet 402(10414):1788\u20131801","journal-title":"Lancet"},{"issue":"9","key":"4533_CR3","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1097\/IJG.0000000000002605","volume":"34","author":"HW Bae","year":"2025","unstructured":"Bae HW, Lee EJ, Jung JJ et al (2025) Effectiveness and Safety of Omidenepag Isopropyl 0.002% Ophthalmic Solution in Treatment-Naive Patients With Primary Open Angle Glaucoma: A Prospective Multicenter Phase IV Study. J Glaucoma 34(9):651\u2013657","journal-title":"J Glaucoma"},{"key":"4533_CR4","doi-asserted-by":"crossref","unstructured":"Fineide F, Magn\u00f8 M, Dahl\u00f8 K et al (2024) Topical glaucoma medications\u2009\u2013\u2009Possible implications on the meibomian glands. 102(7):735\u2013748","DOI":"10.1111\/aos.16728"},{"issue":"2","key":"4533_CR5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jamda.2019.10.022","volume":"21","author":"LE Davies","year":"2020","unstructured":"Davies LE, Spiers G, Kingston A et al (2020) Adverse Outcomes of Polypharmacy in Older People: Systematic Review of Reviews. J Am Med Dir Assoc 21(2):181\u2013187","journal-title":"J Am Med Dir Assoc"},{"issue":"1","key":"4533_CR6","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","volume":"17","author":"N Masnoon","year":"2017","unstructured":"Masnoon N, Shakib S, Kalisch-Ellett L et al (2017) What is polypharmacy? A systematic review of definitions. BMC Geriatr 17(1):230","journal-title":"BMC Geriatr"},{"key":"4533_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13010184","author":"E Takao","year":"2023","unstructured":"Takao E, Ichitani A, Tanito M (2023) Estimation of topical glaucoma medication over-prescription and its associated factors. J Clin Med. https:\/\/doi.org\/10.3390\/jcm13010184","journal-title":"J Clin Med"},{"issue":"6","key":"4533_CR8","doi-asserted-by":"publisher","first-page":"694","DOI":"10.5301\/ejo.5000977","volume":"27","author":"F P\u00e9rez-Bartolom\u00e9","year":"2017","unstructured":"P\u00e9rez-Bartolom\u00e9 F, Mart\u00ednez-de-la-Casa JM, Arriola-Villalobos P et al (2017) Ocular surface disease in patients under topical treatment for glaucoma. Eur J Ophthalmol 27(6):694\u2013704","journal-title":"Eur J Ophthalmol"},{"issue":"2","key":"4533_CR9","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1177\/11206721241272179","volume":"35","author":"CA Nnubia","year":"2025","unstructured":"Nnubia CA, Nwosu SNN, Okpala NE et al (2025) Multiple medications and quality of life of Nigerians with primary open angle glaucoma. Eur J Ophthalmol 35(2):576\u2013581","journal-title":"Eur J Ophthalmol"},{"issue":"3","key":"4533_CR10","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/IJG.0000000000001730","volume":"30","author":"AR Patel","year":"2021","unstructured":"Patel AR, Schwartz GF, Campbell JH et al (2021) Economic and Clinical Burden Associated With Intensification of Glaucoma Topical Therapy: A US Claims-based Analysis. J Glaucoma 30(3):242\u2013250","journal-title":"J Glaucoma"},{"issue":"9","key":"4533_CR11","doi-asserted-by":"publisher","first-page":"e222","DOI":"10.1097\/OPX.0000000000000542","volume":"92","author":"N Ramli","year":"2015","unstructured":"Ramli N, Supramaniam G, Samsudin A et al (2015) Ocular Surface Disease in Glaucoma: Effect of Polypharmacy and Preservatives. Optom Vis Sci 92(9):e222\u2013e226","journal-title":"Optom Vis Sci"},{"issue":"9","key":"4533_CR12","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1016\/j.jfo.2021.03.008","volume":"44","author":"H Lajmi","year":"2021","unstructured":"Lajmi H, Chelly Z, Choura R et al (2021) Relationship between OSDI score and biomicroscopic ocular surface damages in glaucomatous patients treated with preserved antiglaucomatous eye drops. J Fr Ophtalmol 44(9):1326\u20131331","journal-title":"J Fr Ophtalmol"},{"issue":"6","key":"4533_CR13","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1177\/1120672120901698","volume":"30","author":"E Do\u011fan","year":"2020","unstructured":"Do\u011fan E, \u00c7ak\u0131r BK, Aksoy N et al (2020) Effects of topical antiglaucomatous medications on central corneal epithelial thickness by anterior segment optical coherence tomography. Eur J Ophthalmol 30(6):1519\u201324","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"4533_CR14","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/IJG.0000000000001677","volume":"30","author":"I Halkiadakis","year":"2021","unstructured":"Halkiadakis I, Vernikou A, Tzimis V et al (2021) Assessment of corneal epithelium thickness in glaucomatous patients undergoing medical treatment. J Glaucoma 30(1):44\u20139","journal-title":"J Glaucoma"},{"key":"4533_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10163464","author":"M Nam","year":"2021","unstructured":"Nam M, Kim SW (2021) Changes in corneal epithelial thickness induced by topical antiglaucoma medications. J Clin Med. https:\/\/doi.org\/10.3390\/jcm10163464","journal-title":"J Clin Med"},{"issue":"1","key":"4533_CR16","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.11.1.4","volume":"11","author":"Y Ye","year":"2022","unstructured":"Ye Y, Xu Y, Yang Y et al (2022) Wide corneal epithelial thickness mapping in eyes with topical antiglaucoma therapy using optical coherence tomography. Transl Vis Sci Technol 11(1):4","journal-title":"Transl Vis Sci Technol"},{"issue":"10","key":"4533_CR17","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1007\/s00417-023-06050-z","volume":"261","author":"K Latif","year":"2023","unstructured":"Latif K, Nishida T, Moghimi S et al (2023) Quality of life in glaucoma. Graefes Arch Clin Exp Ophthalmol 261(10):3023\u20133030","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"4533_CR18","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.ophtha.2019.10.022","volume":"127","author":"PA Newman-Casey","year":"2020","unstructured":"Newman-Casey PA, Niziol LM, Gillespie BW et al (2020) The Association between Medication Adherence and Visual Field Progression in the Collaborative Initial Glaucoma Treatment Study. Ophthalmology 127(4):477\u2013483","journal-title":"Ophthalmology"},{"issue":"5","key":"4533_CR19","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/IJG.0000000000002011","volume":"31","author":"JS Lee","year":"2022","unstructured":"Lee JS, Park S, Seong GJ et al (2022) Long-term Intraocular Pressure Fluctuation Is a Risk Factor for Visual Field Progression in Advanced Glaucoma. J Glaucoma 31(5):310\u2013316","journal-title":"J Glaucoma"},{"issue":"5","key":"4533_CR20","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1093\/her\/cyv034","volume":"30","author":"B Sleath","year":"2015","unstructured":"Sleath B, Carpenter DM, Blalock SJ et al (2015) Applying the resources and supports in self-management framework to examine ophthalmologist-patient communication and glaucoma medication adherence. Health Educ Res 30(5):693\u2013705","journal-title":"Health Educ Res"},{"issue":"7","key":"4533_CR21","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.ophtha.2015.03.026","volume":"122","author":"PA Newman-Casey","year":"2015","unstructured":"Newman-Casey PA, Robin AL, Blachley T et al (2015) The Most Common Barriers to Glaucoma Medication Adherence: A Cross-Sectional Survey. Ophthalmology 122(7):1308\u20131316","journal-title":"Ophthalmology"},{"key":"4533_CR22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jtos.2024.08.001","volume":"34","author":"MY Kahook","year":"2024","unstructured":"Kahook MY, Rapuano CJ, Messmer EM et al (2024) Preservatives and ocular surface disease: A review. Ocul Surf 34:213\u2013224","journal-title":"Ocul Surf"},{"issue":"3","key":"4533_CR23","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s10792-019-01236-z","volume":"40","author":"A Guarnieri","year":"2020","unstructured":"Guarnieri A, Carnero E, Bleau AM et al (2020) Relationship between OSDI questionnaire and ocular surface changes in glaucomatous patients. Int Ophthalmol 40(3):741\u2013751","journal-title":"Int Ophthalmol"},{"issue":"1","key":"4533_CR24","doi-asserted-by":"publisher","first-page":"P71","DOI":"10.1016\/j.ophtha.2020.10.022","volume":"128","author":"SJ Gedde","year":"2021","unstructured":"Gedde SJ, Vinod K, Wright MM et al (2021) Primary Open-Angle Glaucoma Preferred Practice Pattern\u00ae. Ophthalmology 128(1):P71\u2013p150","journal-title":"Ophthalmology"},{"issue":"6","key":"4533_CR25","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1097\/ICO.0000000000001575","volume":"37","author":"H Batawi","year":"2018","unstructured":"Batawi H, Lollett IV, Maliakal C et al (2018) A Comparative Study of Central Corneal Epithelial, Stromal, and Total Thickness in Males With and Without Primary Open-Angle Glaucoma. Cornea 37(6):712\u2013719","journal-title":"Cornea"},{"key":"4533_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/ph18060868","author":"P Miklaszewski","year":"2025","unstructured":"Miklaszewski P, Gadamer AM, Janiszewska-Bil D et al (2025) Impact of antiglaucoma drug number and class on corneal epithelial thickness measured by OCT. Pharmaceuticals (Basel). https:\/\/doi.org\/10.3390\/ph18060868","journal-title":"Pharmaceuticals (Basel)"},{"issue":"9","key":"4533_CR27","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1111\/ceo.13857","volume":"48","author":"L Mastropasqua","year":"2020","unstructured":"Mastropasqua L, Brescia L, Oddone F et al (2020) Conjunctival thickness as a predictive imaging biomarker for the glaucoma filtration surgery outcome: An optical coherence tomography study. Clin Exp Ophthalmol 48(9):1192\u20131200","journal-title":"Clin Exp Ophthalmol"},{"issue":"4","key":"4533_CR28","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1089\/jop.2018.0124","volume":"35","author":"S Tekin","year":"2019","unstructured":"Tekin S, Seven E, Batur M (2019) Evaluation of Antiglaucomatous Drops on Conjunctival Thickness in Patients with Primary Open-Angle Glaucoma. J Ocul Pharmacol Ther 35(4):216\u2013222","journal-title":"J Ocul Pharmacol Ther"},{"issue":"10","key":"4533_CR29","doi-asserted-by":"publisher","first-page":"e879","DOI":"10.1097\/IJG.0000000000000490","volume":"25","author":"L Issa de Fendi","year":"2016","unstructured":"Issa de Fendi L, Cena de Oliveira T, Bigheti Pereira C et al (2016) Additive effect of risk factors for trabeculectomy failure in glaucoma patients: a risk-group from a cohort study. J Glaucoma 25(10):e879\u2013e83","journal-title":"J Glaucoma"},{"key":"4533_CR30","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.2147\/OPTH.S308228","volume":"15","author":"A Pantalon","year":"2021","unstructured":"Pantalon A, Feraru C, Tarcoveanu F et al (2021) Success of Primary Trabeculectomy in Advanced Open Angle Glaucoma. Clin Ophthalmol 15:2219\u20132229","journal-title":"Clin Ophthalmol"},{"issue":"6","key":"4533_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0325319","volume":"20","author":"S Chansangpetch","year":"2025","unstructured":"Chansangpetch S, Pongpisitkul P, Tipparut K et al (2025) Incidence of and factors associated with brimonidine allergy. PLoS One 20(6):e0325319","journal-title":"PLoS One"},{"issue":"11","key":"4533_CR32","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.ophtha.2025.07.009","volume":"132","author":"Y Hsia","year":"2025","unstructured":"Hsia Y, Wang C, Su CC et al (2025) Efficacy and Drug Interactions of Glaucoma Medications: A Systematic Review and Component Network Meta-analysis. Ophthalmology 132(11):1304\u20131316","journal-title":"Ophthalmology"},{"issue":"9","key":"4533_CR33","first-page":"3137","volume":"12","author":"V Toumanidou","year":"2023","unstructured":"Toumanidou V, Diafas A, Georgiadis N et al (2023) Fixed versus Unfixed Combination of Topical Latanoprost\/Timolol for Glaucoma: An Observational Study Investigating the Level of Adherence and Ocular. Surf Health 12(9):3137","journal-title":"Surf Health"},{"issue":"3","key":"4533_CR34","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/pds.3566","volume":"23","author":"A Miguel","year":"2014","unstructured":"Miguel A, Henriques F, Azevedo LF et al (2014) Ophthalmic adverse drug reactions to systemic drugs: a systematic review. Pharmacoepidemiol Drug Saf 23(3):221\u2013233","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-026-04533-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-026-04533-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-026-04533-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T02:22:23Z","timestamp":1783131743000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-026-04533-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,4]]},"references-count":34,"alternative-id":["4533"],"URL":"https:\/\/doi.org\/10.1007\/s11845-026-04533-6","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,4]]},"assertion":[{"value":"29 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}